Statement Of Changes In Equity [Abstract]

Pharming Group N.V. - Filing #5829944

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	—	275,489,000 USD	488,990,000 USD	7,769,000 USD	—	—	209,000 USD	221,061,000 USD	—	218,781,000 USD	—	265,262,000 USD	2,057,000 USD	—	—	478,431,000 USD	—	7,669,000 USD	204,638,000 USD	8,737,000 USD	462,297,000 USD	256,431,000 USD	7,509,000 USD
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	— USD	— USD	— USD	—	—	—	11,841,000 USD	11,841,000 USD	—	—	10,548,000 USD	—	— USD	—	—	10,548,000 USD	— USD	—	— USD	—	—	—	—	—	—
Other comprehensive income	11,901,000 USD	— USD	— USD	—	—	—	— USD	11,901,000 USD	—	—	7,103,000 USD	—	7,103,000 USD	—	—	— USD	— USD	—	— USD	—	—	—	—	—	—
Comprehensive income	10,346,000 USD	— USD	— USD	—	—	—	13,396,000 USD	23,742,000 USD	—	—	3,445,000 USD	—	7,103,000 USD	—	—	10,548,000 USD	— USD	—	— USD	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	— USD	— USD	— USD	—	—	—	11,248,000 USD	11,248,000 USD	—	—	9,251,000 USD	—	— USD	—	—	9,251,000 USD	— USD	—	— USD	—	—	—	—	—	—